Science Explorer Interactive view Map
Company · Mountain View · United States

ChemoCentryx (United States)

chemocentryx.comROR OpenAlex
World rank, all time
#13,134
of 42,892
Rank in United States
#2,873
of 8,685
Research works
131
▲ 10% vs 2013–17
Citations
5.5k
42.4 per fractional work
Top-10% rate
5.8%
record average 16.5%
Open access
46%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.04× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 12.03× its world share, 2 worksImmunology and Micro…Computer Science: 0.25× its world share, 0 worksComputer ScienceEngineering: 0.30× its world share, 1 worksEngineeringPhysics and Astronomy: 0.34× its world share, 0 worksPhysics and AstronomyDentistry: 0.98× its world share, 0 worksDentistryHealth Professions: 0.18× its world share, 0 worksHealth ProfessionsMedicine: 3.83× its world share, 10 worksMedicineEconomics, Econometrics and Finance: 0.28× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.0×. Every wedge is a field page.

Who are the top researchers at ChemoCentryx (United States)?

Ranked on the composite score, Thomas J. Schall, James J. Campbell and Pirow Bekker lead among researchers whose main affiliation is ChemoCentryx (United States).

  1. 1 Thomas J. Schall United States · #22,244 worldwide 638 citations · 41 works
  2. 2 James J. Campbell United States · #71,454 worldwide 343 citations · 28 works
  3. 3 Pirow Bekker United States · #196,470 worldwide 160 citations · 22 works
  4. 4 Chris Li United States · #1,331,748 worldwide 15 citations · 59 works
  5. 5 Linda Ertl United States · #1,604,198 worldwide 5 citations · 15 works
All ranked researchers at ChemoCentryx (United States)

Which keywords describe research at ChemoCentryx (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Angiogenesis, Therapeutic Targets, Immune Responses, Cell Migration, Host Defense, Cancer Metastasis and Chemokine Receptors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation36▲ 12×31 topics
  2. Angiogenesis19▲ 35×6 topics
  3. Therapeutic Targets17▲ 57×5 topics
  4. Immune Responses17▲ 133×2 topics
  5. Cell Migration16▲ 144×2 topics
  6. Host Defense16▲ 188×3 topics
  7. Cancer Metastasis16▲ 380×1 topic
  8. Chemokine Receptors16▲ 759×1 topic
  9. Cancer12▲ 6.4×12 topics
  10. Tumor Microenvironment11▲ 23×7 topics
  11. Immunity10▲ 23×4 topics
  12. Innate Immunity9▲ 21×6 topics
  13. TGF-ß6▲ 29×3 topics
  14. Cancer Immunotherapy6▲ 33×3 topics
  15. Immune Response6▲ 7.3×8 topics
  16. Genetics6▲ 5.8×5 topics
  17. Dendritic Cells6▲ 38×2 topics
  18. Immunotherapy6▲ 6.7×10 topics
  19. Glycosylation6▲ 19×2 topics
  20. NK Cell Recognition6▲ 41×1 topic
  21. Natural Killer Cells6▲ 41×1 topic
  22. Antigen Presentation5▲ 40×2 topics
  23. Immune Checkpoint Blockade5▲ 71×1 topic
  24. PD-1 and PD-L15▲ 71×1 topic
  25. Tumor Antigen5▲ 48×1 topic
  26. Vaccine Adjuvants5▲ 48×1 topic
  27. Chemotherapy5▲ 5.1×10 topics
  28. Rituximab5▲ 22×4 topics
  29. Metabolism5▲ 5.5×3 topics
  30. Monoclonal Antibodies5▲ 24×3 topics
  31. Therapeutic Antibodies4▲ 26×2 topics
  32. Activation4▲ 93×1 topic
  33. Antibody Engineering4▲ 33×1 topic
  34. Fc Receptors4▲ 33×1 topic
  35. Macrophage4▲ 58×1 topic
  36. Regulatory T Cells4▲ 28×4 topics
  37. Autoimmunity4▲ 14×4 topics
  38. Immune System4▲ 9.2×3 topics
  39. Thrombosis3▲ 12×3 topics
  40. Metastasis3▲ 7.5×6 topics

Which research topics does ChemoCentryx (United States) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Vasculitis and related conditions, Renal Diseases and Glomerulopathies and Hidradenitis Suppurativa and Treatments.

Cancer Immunotherapy and Biomarkers: 2 fractional worksVasculitis and related conditions: 1 fractional worksRenal Diseases and Glomerulopathies: 1 fractional worksHidradenitis Suppurativa and Treatments: 1 fractional worksColorectal and Anal Carcinomas: 1 fractional worksChronic Kidney Disease and Diabetes: 1 fractional worksComplement system in dis…1Complement system in diseases: 1 fractional worksChemokine receptors and …1Chemokine receptors and signaling: 1 fractional worksOtitis Media and Relapsi…0Otitis Media and Relapsing Polychondritis: 0 fractional worksCoagulation, Bradykinin,…0Coagulation, Bradykinin, Polyphosphates, and Angioedema: 0 fractional works
OncologyPulmonary and Respiratory MedicineNephrologyDermatology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
  2. 2 Vasculitis and related conditions Pulmonary and Respiratory Medicine 1 works
  3. 3 Renal Diseases and Glomerulopathies Nephrology 1 works
  4. 4 Hidradenitis Suppurativa and Treatments Dermatology 1 works
  5. 5 Colorectal and Anal Carcinomas Surgery 1 works
  6. 6 Chronic Kidney Disease and Diabetes Nephrology 1 works
  7. 7 Complement system in diseases Immunology 1 works
  8. 8 Chemokine receptors and signaling Oncology 1 works
  9. 9 Otitis Media and Relapsing Polychondritis Rheumatology 0 works
  10. 10 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.3%not open53.7%

World: 28% of research is openly available.

with international co-authors20.3%domestic only79.7%

World: 19% is written across borders.

How has ChemoCentryx (United States)'s research output changed?

Output in 2018–2022 was 10% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mountain View

All research institutions in Mountain View

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.